<DOC>
	<DOCNO>NCT01082562</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability , serum concentration pharmacodynamic effect serum low-density lipoprotein ( LDL ) cholesterol single multiple subcutaneous intravenous dos BMS-844421 healthy subject ( SAD ) subject elevate cholesterol ( MAD ) .</brief_summary>
	<brief_title>Safety Study BMS-844421 Treatment Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Healthy Subjects ( SAD ) Healthy Subjects ( MAD ) untreated elevate cholesterol Body Mass Index ( BMI ) 18 30 kg/mÂ² inclusive Women childbearing potential men , age 18 45 Any significant acute chronic medical illness History liver renal disorder Prior use prescription overthecounter lipid lower drug , within 8 week prior study drug administration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>